Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | MTB | IBN |
|---|---|---|
| Price | $214.71 | $27.38 |
| Change today | ▼ 1.33% | ▼ 0.64% |
| Market cap | $31.01B | $98.25B |
| Return, 3 months | – | -4.7% |
| Return, year to date | – | -7.4% |
| Return, 1 year | – | -9.6% |
| P/E (TTM) | 11.4 | 17.6 |
| P/B | 1.2 | 2.6 |
| P/E percentile vs own 5y | 36th | 17th |
| Dividend yield | 2.79% | 0.85% |
| Revenue growth (YoY, latest qtr) | +4.1% | +7.7% |
| Net profit growth (YoY) | +14.2% | +12.6% |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | 29.2% | 24.8% |
| Return on equity | 11.1% | 15.8% |
| Analyst target vs. price | +22.9% | – |
| Analyst buy share | 31% | 100% |
| RSI (14) | – | 34 |
| 30-day volatility | – | 19.7% |
| Max drawdown, 1 year | – | -23.5% |
| Trend read | – | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
